Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Biobehavioral Mechanisms of Activity and Loss of Control Eating in Children

10 settembre 2026 aggiornato da: Dr. Kathryn Smith, The University of Texas at Dallas

Loss of control eating in children and adolescents is associated with a host of negative physical and psychological health outcomes and a prognostic marker for development of eating disorders. However, there is a lack of longitudinal research investigating the developmental processes contributing to loss of control eating in youth. While physical activity, sedentary behavior, and self-regulation have been linked to the regulation of eating, no research has examined the mechanistic processes by which these domains may together impact loss of control eating during childhood and adolescence. Furthermore, given that these factors (i.e., activity, self-regulation, and eating behavior) vary considerably from moment-to-moment, it is imperative to utilize methodology that can capture momentary, real-time fluctuations in these domains. Therefore, the current study proposes to use a biobehavioral, multi-method approach integrating neuroimaging, accelerometry, neurocognitive assessments, and ecological momentary assessment (EMA) to study how physical activity and sedentary behavior patterns and self-regulation influence loss of control eating and related eating disorder psychopathology from late childhood to adolescence, which is a critical transitional developmental period. Male and female children aged 10-12 at baseline (N=200) will be recruited to complete annual assessments for 3 years.

Aim 1 (momentary) - Examine momentary associations between physical activity patterns, self-regulatory mechanisms (i.e., inhibitory control, emotion functioning, and food-related reward anticipation) and loss of control eating in daily life using multi-method ambulatory assessment. Hypothesis 1a: Momentary decreases in physical activity and increases in sedentary behavior, compared to one's usual level, will be associated with increases in loss of control eating. Hypothesis 1b: Momentary decreases in self-regulatory mechanisms (i.e., decreases in inhibitory control, emotion regulation, and positive affect, and increases in negative affect and food-related reward anticipation) will explain (i.e., mediate) associations between decreases in physical activity/increases in sedentary behavior and subsequent increases in loss of control eating.

Aim 2 (longitudinal) - Examine longitudinal associations between physical activity patterns, self-regulatory mechanisms, and binge eating and related eating pathology (i.e., loss of control eating, binge episodes, eating disorder onset, global eating psychopathology) using multimethod ambulatory assessment and functional magnetic resonance imaging (fMRI). Hypothesis 2: Across a three-year follow-up, children who show greater decreases in physical activity and increases in sedentary behavior, compared to other children, will demonstrate greater decreases in self-regulatory capacity (i.e., decreases in inhibitory control, emotion regulation, and positive affect, and increases in negative affect and food-related reward anticipation), which in turn will predict increases in binge eating and related eating pathology by year three. The hypothesis will be evaluated using self-regulation indices measured via EMA (Hypothesis 2a) and via task-evoked neural activations during fMRI (Hypothesis 2b).

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The study involves a clinical interview, physical measurements, questionnaires, brain imaging (MRI), and a 10-day monitoring period during which participants will complete mobile phone surveys and physical activity will be monitored. Study sessions occur once a year for 3 years and will include virtual and in-person visits, each of which will last between 1-2 hours.

Procedure:

Screening - Study advertisements will direct interested parents/legal guardians of children to an online screening (via QR code). The online screening survey will be administered by REDCap and completed on their device. The screener will also include a document with mental health and eating disorder referral information because the screening process may raise awareness of these concerns. Potentially eligible families will be contacted via email or phone to set up a time for the study visit at UTD.

Study visits - Participants will complete 3 annual data collection visits that will be 12 months apart (Year 1, 2, and 3). During Years 1-2, participants and parents/guardians will complete a virtual session with researchers followed by an in-person visit at the UTD Brain Health Imaging Center (BHIC) where participants will complete the neuroimaging (fMRI) protocol. The Year 3 study visit will take place at Dr. Smith's research laboratory in the UTD Department of Psychology. During scheduling of study visits involving fMRI (Years 1-2), families will also be informed that participants will be asked to abstain from eating for 4 hours prior to fMRI to standardize procedures and capture representative physiological states prior to eating meals (during which inhibitory control, emotion regulation, and reward processing may influence subsequent eating behavior). We will provide mental health and eating disorder referral information to all families at study visits because the assessment process may raise awareness of concerns the parent was not previously aware of.

Informed by published ethical guidance for pediatric research developed for the NIH-funded Adolescent Brain and Cognitive Development (ABCD) study, parents will not be shown their child's individual interview or survey responses, with two exceptions: (1) current suicidal ideation or self-harm, and (2) eating disorder symptoms indicating the child is at serious medical or psychiatric risk (e.g., significantly low weight/weight loss or dangerous compensatory behaviors such as frequent purging). This will be operationalized as evidence of:

  • BMI percentile below the 5th percentile for age/sex
  • Rapid and significant weight loss
  • Self-report during the clinical interview indicating compensatory behaviors (self-induced vomiting, laxative/diuretic misuse, fasting, compulsive exercise) occurring several times per week For consistency, and to protect the validity of adolescent self-report, we align the threshold of disclosing eating disorders with the same imminent/serious-risk standard as outlined in the ABCD study.

Year 1:

Virtual session - At the first virtual session, parents/guardians and participants will complete the initial informed consent and assent process with researchers virtually. During the informed consent process and in the consent form, it will also be explained that participants may be ruled out after enrollment if they do not meet study eligibility criteria (e.g., based on information provided during the clinical interview or their height/weight) or if MRI is not appropriate for participants due to contraindications. Following the informed consent process, participants' eligibility will be confirmed based on a clinical interview (Child Eating Disorder Examination administered virtually) and anthropometric (height/weight/waist circumference) measurements at the in-person visit. During the virtual session, participants and parents/guardians will complete self-report surveys online and receive mobile phone and accelerometer instructions.

In-person visit (UTD Brain Health Imaging Center) - Participants will complete a neuroimaging protocol and anthropometric assessments at the UTD Brain Health Imaging Center (accompanied by their parent/guardian), which will be scheduled within 2 weeks of the virtual session.

10-day data collection - Over the next 10 days after the in-person visit, participants will proceed through a 10-day data collection period in their daily life. This includes an ecological momentary assessment (EMA) protocol during which participants will be asked to proceed with their daily routines as normal. Participants will also wear an accelerometer across all 10 days. Staff will contact families by phone during the 10-day monitoring period to encourage compliance and address technical issues.

Year 2:

Virtual session - The consent and assent process will be repeated. Participants will repeat the clinical interview, and participants and parents/guardians will complete online surveys.

In-person visit (UTD Brain Health Imaging Center) - Participants will repeat the neuroimaging protocol and anthropometric assessments at the UTD Brain Health Imaging Center (accompanied by their parent/guardian), which will be scheduled within 2 weeks of the virtual session.

10-day data collection - Participants will repeat the 10-day data collection period.

Year 3:

In-person visit (UTD Psychology Department) - The consent and assent process will be repeated. Participants will repeat the clinical interview, anthropometric assessments, and participants and parents/guardians will complete online surveys.

10-day data collection - Participants will repeat the 10-day data collection period.

Data collection measures will include the following:

Anthropometric assessment (Years 1-3) - At each in-person study visit, height, weight, and waist circumference of the participant will be measured in duplicate using an electronically calibrated digital scale and professional stadiometer to the nearest 0.1 kg and 0.1 cm, respectively. Blind weight will be measured (i.e., they will not see their weight) to mitigate any distress or reactivity. These measurements will be completed at the BHIC in Years 1-2, and in Dr. Smith's research laboratory during Year 3.

Interview (Years 1-3) - Each year, participants will complete a clinical interview 9Child Eating Disorder Examination [ChEDE] diagnostic modules). This interview will be administered virtually in Years 1-2 and in-person at UT Dallas in Year 3. The ChEDE will be used to confirm eligibility at Year 1 and for descriptive purposes in Years 2-3.

Self-report questionnaires (Years 1-3) - Participants will report on their gender identity and sexual orientation, and they will complete a series of self-report questionnaires online.

Neuroimaging (Years 1-2) - In Years 1 and 2, participants will complete an fMRI protocol at the BHIC.

Prior to fMRI participants will also complete online surveys that assess exercise over the previous 24 hours, as well as current hunger state (using a visual analog scale from 0 [not hungry at all] to 10 [very hungry]) that will be considered as covariates in analyses. Participants will be asked to confirm they have abstained from eating for 4 hours prior to MRI. Parent/guardians will be asked to confirm eating abstinence, and imaging will be done at the end of the study session (i.e., after interview/questionnaire assessments) to ensure children have not eaten recently.

After completing pre-scan measures, participants will complete a practice session in the MR (magnetic resonance) simulator to familiarize participants with the scanning environment. Then they will complete the MRI protocol which includes complete three tasks in a randomized order while brain activity is being recorded with fMRI. Tasks will be projected on a screen located at the rear of the magnet and viewed via a head coil mirror. A response keypad will record task responses. The neuroimaging protocol will first acquire T2, T1, field map, and scout scans (~8-10 min) then two runs of the go/no-go task (~5 min/run), two runs of the visual food task (~6 min/run), and four runs of the emotion regulation task (~4 min/run), totaling 46-48 minutes of scanning time. Participants may take breaks as needed between runs.

Ecological momentary assessment (EMA; Years 1-3) - Across the 3 years, participants will complete an annual 10-day EMA protocol in their natural environment using an EMA application for smartphones. Participants will use a smartphone (either their own or one provided) to complete surveys, up to 4 times during non-school time on weekdays (morning wake-up time; 3:30pm-8pm) and up to 7 times on weekend days (9am-9pm). EMA measures will be collected using (1) signal-contingent reporting, which requires youth to complete assessments occurring at various times throughout the day in response to semi-random prompts, and (2) event-contingent reporting, which requires youth complete a survey after they engage in an eating episode. Semi-random prompts will be generated in stratified random sampling windows, with one prompt randomly occurring during each window. Youth will not complete random surveys on weekdays while at school to prevent classroom interruptions. However, they will be asked to record lunch on weekdays at school. At each semi-random signal, participants will also be prompted to report any missed eating episodes. Participants will receive information and training in the completion of EMA reports and behavioral tasks on the smartphone. Participants will be instructed not to complete entries at times when they feel they are not able or when safety is a concern. However, participants will be encouraged to complete the entry as soon as possible when able and will receive reminder prompts. Up to two reminder prompts will be sent within 30 minutes of the initial prompt, after which time the survey will close. Staff will call participants and their caregivers halfway through the protocol to give compliance feedback and to answer questions.

Ambulatory assessment (Years 1-3) - Physical activity and sedentary time will be measured using wrist-worn accelerometers. Participants will wear accelerometers continuously across 10-day monitoring period each year. Activity counts will be recorded in 10-second epochs. Participants will be provided with an accelerometer at each of the in-person visits, and parents/guardians will be provided with a self-addressed prepaid package to return the device after the 10-day monitoring period.

Tipo di studio

Interventistico

Iscrizione (Stimato)

200

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • California
      • Los Angeles, California, Stati Uniti, 90089
        • University of Southern California
        • Contatto:
    • Texas
      • Richardson, Texas, Stati Uniti, 75080
    • Virginia
      • Fairfax, Virginia, Stati Uniti, 22030
        • George Mason University
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  1. Can read and speak English.
  2. At-risk for loss of control eating will be over-sampled (representing minimum 30% of sample) to capture sufficient variability across time in loss of control eating, the online screener will include the Eating Disorders Examination Questionnaire-Short Parent Version (EDE-QS-P). At-risk for loss of control eating is defined on the EDE-QS-P as a global score at least 1 standard deviation above the mean EDE-QS-P score observed among parents of children without eating disorders (i.e., global score > 1.2).

Exclusion Criteria:

  1. Diagnosis of an eating disorder other than binge-eating disorder or subthreshold binge-eating disorder (i.e., binge-eating disorder of low frequency/limited duration), or presence of compulsive exercise as assessed by the Child Eating Disorder Examination.
  2. Health issues that limit physical activity.
  3. Intellectual disability (assessed with the Child and Adolescent Intellectual Disability Screening Questionnaire embedded within the online eligibility screener), which would interfere with completing ecological momentary assessment.
  4. Pregnancy.
  5. Acute suicidality (screened using item 9 on the Patient Health Questionnaire-Adolescent).
  6. Presence of conditions that would make fMRI unsafe (e.g., pacemaker), as assessed by an MRI screening form.
  7. Undergoing eating disorder or weight loss treatment.
  8. Classified as underweight by a body mass index percentile <5% adjusted for sex and age (body mass index z-score<-2.0).
  9. Schizophrenia, substance use disorders, severe neurological disorder (e.g., epilepsy, brain injury), or diabetes (per caregiver self-report).

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Experimental
Participants will be assigned all three behavioral tasks.

This task will assess participants' general and food-related inhibitory control.

Participants will be instructed to press a button to "go" cues and withhold responses to "no-go" cues. In one run, low caloric food images will be the "go" cues, and high caloric food images will be the "no-go" cues. In another run, images of school supplies will be the "go" cues, and toys will be the "no-go" cues.

This task will measure participants' food-related reward processing and food cue reactivity. Participants will view food and non-food images, and brain activity will be assessed while viewing images.
This task will assess participants' ability to modulate negative affect in response to emotionally evocative images. Negative and neutral pictures will be selected from the IAPS database using criteria analogous to prior research. At the start of each trial, an instruction word will be presented ("decrease" or "look") for 4 sec, after which a picture will be presented for 8 sec. The pictures will be negative if the instruction is "decrease" (emotion regulation instruction), negative or neutral if the instruction is "look" (non-regulation). This is followed by a rating of negative affect ranging from 1="'weak" and 4="strong" (4 sec), and then the word "relax" (4 sec). The combinations of instruction and pictures yields 3 trial types: decrease negative (reappraisal), look negative (nonregulation) and look neutral (non-emotional). A total of 72 trials will be given (24 of each trial type) over 4 runs (~4 min/run).

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Inhibitory control
Lasso di tempo: Baseline during visit 1, and one year later at visit 2
The behavioral outcome will be unsuccessful inhibition during no-go trials (commission error rate; i.e., the number of failures of inhibition divided by the total number of no-go trial), calculated separately for food and non-food. Changes in brain activity (through fMRI) will also be examined. For each condition (i.e., food and non-food stimulus blocks), analyses will evaluate contrast of successful no-go versus implicit baseline (fixation cross) and successful no-go versus unsuccessful no-go trials. Percent change in BOLD response within priori regions of interest (ROIs) will be extracted from these contrasts and used in subsequent analyses. ROIs (based on prior research) will include the inferior frontal gyrus (IFG), ventromedial prefrontal cortex (vmPFC), dorsolateral prefrontal cortex (dlPFC), and ventrolateral prefrontal cortex (vlPFC), as defined by the Harvard-Oxford Cortical Structural Atlas.
Baseline during visit 1, and one year later at visit 2
Food-related reward processing
Lasso di tempo: Baseline during visit 1, and one year later at visit 2
The outcome measure will assess changes in brain activity, as measured by fMRI, during exposure to food and non-food images. A general linear model will include three regressors: high-calorie food stimuli, low-calorie food stimuli, and non-food stimuli. Analyses will examine contrasts comparing food stimuli (combined high-calorie and low-calorie food conditions) with non-food stimuli to evaluate differences in BOLD activation within a priori regions of interest (ROIs). Percent change in BOLD signal within these ROIs will be extracted and used in subsequent analyses. Based on prior meta-analytic findings, ROIs will include regions implicated in reward and motivation (amygdala, orbitofrontal cortex, nucleus accumbens, and dorsal striatum), homeostatic regulation (hypothalamus), inhibitory control (dorsolateral prefrontal cortex [dlPFC]), and gustatory processing (insula).
Baseline during visit 1, and one year later at visit 2
Emotion Processing
Lasso di tempo: Baseline during visit 1, and one year later at visit 2
The outcome measure will assess changes in brain activity, as measured by fMRI, across three task conditions: decrease negative (cognitive reappraisal), look negative (passive viewing of negative stimuli), and look neutral (passive viewing of neutral stimuli). Analyses will focus on the contrast between the decrease negative and look negative conditions to evaluate neural activity associated with emotion regulation. Percent change in the BOLD response within a priori regions of interest (ROIs) will be extracted from this contrast and used in subsequent analyses. A priori ROIs will include anatomically defined masks of the anterior cingulate cortex (ACC), medial prefrontal cortex (mPFC), ventrolateral prefrontal cortex (vlPFC), and dorsolateral prefrontal cortex (dlPFC), as defined by the Harvard-Oxford Cortical Structural Atlas.
Baseline during visit 1, and one year later at visit 2

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 gennaio 2027

Completamento primario (Stimato)

1 settembre 2030

Completamento dello studio (Stimato)

1 settembre 2030

Date di iscrizione allo studio

Primo inviato

10 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 settembre 2026

Primo Inserito (Effettivo)

16 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

16 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • IRB-26-472
  • 1R01MH142463-01 (Sovvenzione/contratto NIH degli Stati Uniti)
  • UP-26-00531 (Altro identificatore: University of Southern California)
  • STUDY00001354 (Altro identificatore: George Mason University)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified demographic, clinical, survey, ambulatory assessment, and fMRI imaging data.

Periodo di condivisione IPD

Starting when the award ends with no end date.

Tipo di informazioni di supporto alla condivisione IPD

  • LINFA
  • ICF

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .